Project Grant K24AI199258
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Massachusetts General Hospital $453,750 on June 17, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop an innovative high-throughput airway organoid screening platform. This research project, scheduled for completion by May 31, 2027, focuses on identifying novel mechanisms of communication between airway epithelial cells (AECs) and intraepithelial...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Massachusetts General Hospital a $453,750 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, through July 31, 2027. The award funds research investigating neutrophil swarming mechanisms in response to Pseudomonas aeruginosa microcolony aggregates. The research will develop an ex vivo model to elucidate the cellular and molecular...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Massachusetts General Hospital $428,598.42 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective July 1, 2025, through September 26, 2025. This Project Grant supports biomedical research investigating the mechanisms by which extracellular matrix (ECM) stiffness regulates the NLRP3 inflammasome in macrophages. The research addresses a critical gap in...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Boston Children's Hospital a Project Grant totaling $181,892 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on January 21, 2026, with completion expected by September 28, 2028. This award supports research to validate viral metagenomic sequencing of dust samples collected from elementary school classrooms as a novel surveillance methodology for detecting...
- Federal Grant Award Summary Award Details: The National Institute of Allergy and Infectious Diseases (NIAID) awarded Massachusetts General Hospital a Project Grant of $436,454 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 6, 2026, with a project completion date of January 31, 2028. Products and Services: This award funds investigator-initiated biomedical research investigating the gastrointestinal tract's role in systemic alloimmunity following allogeneic...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $197,640 to Massachusetts General Hospital under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 16, 2025, for a five-year project period concluding June 30, 2030. This Project Grant funds investigator-initiated research to advance understanding of sepsis immunopathogenesis through single-cell ribonucleic acid sequencing (scRNA-seq) and functional immunological...
- Federal Project Grant Award Summary Massachusetts General Hospital received a $439,216 Project Grant award dated July 8, 2025, from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct a two-year research initiative examining the role of cholinergic neuroimmune signaling pathway disruption in Hirschsprung-associated enterocolitis (HAEC). The research will characterize neuroimmune mechanisms underlying...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Boston Children's Hospital a Project Grant of $489,500 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 24, 2025, with a completion date of June 30, 2027. The award funds structural research aimed at determining the high-resolution three-dimensional structure of the full-length nucleocapsid (N) protein of Severe Acute Respiratory Syndrome Coronavirus 2...
- Federal Grant Award Summary The University of Massachusetts Medical School received a $472,210 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective June 23, 2025, through May 31, 2027. The grant supports biomedical research investigating T-cell mediated neutrophil recruitment during lung infection, with specific focus on understanding how prior respiratory pathogen exposure...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Massachusetts General Hospital $160,954 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on January 29, 2026, with a completion date of July 31, 2026. This Project Grant supports investigator-initiated biomedical research focused on defining the mechanisms by which human macrophages kill the intracellular bacterial pathogen Shigella flexneri, a leading cause of...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $216,098 Project Grant to Massachusetts General Hospital (MGH) on May 21, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The five-year project, extending through April 30, 2031, supports research and mentoring focused on understanding how environmental factors—particularly indoor humidity—influence the virome and microbiome in relation to respiratory infection risk across pediatric populations. The grant delivers research services that leverage two existing National Institutes of Health (NIH)-funded randomized controlled trials conducted in Boston, Massachusetts (n=247 children) and Kintampo, Ghana (n=800 children) to investigate biological pathways through which humidity modulates infection risk, including microbiome and virome modulation, host immune alterations, and respiratory virus exposure. The project utilizes hybrid-capture-based viral metagenomics sequencing of built environment and nasal samples to distinguish school versus home acquisition of respiratory viral infections in school-age children. Equal emphasis is placed on mentoring activities designed to develop the next generation of patient-oriented researchers in environmental health, microbiome, and virome research domains. These research and mentoring services are performed at MGH's Research Management Division in Boston, Massachusetts.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $216.1k | 5/25/26 |